Q
Qing Yun Li
Researcher at Shanghai Jiao Tong University
Publications - 42
Citations - 665
Qing Yun Li is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Obstructive sleep apnea & Medicine. The author has an hindex of 9, co-authored 38 publications receiving 381 citations. Previous affiliations of Qing Yun Li include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
The Microbiota-Gut-Brain Axis and Its Potential Therapeutic Role in Autism Spectrum Disorder
Qing Yun Li,Jie Zhou +1 more
TL;DR: Application of modulators of the microbiota-gut-brain axis, such as probiotics, helminthes and certain special diets, may be a promising strategy for the treatment of ASD.
Journal ArticleDOI
Ammonia intercalated flower-like MoS2 nanosheet film as electrocatalyst for high efficient and stable hydrogen evolution.
Fenghua Wang,Maojun Zheng,Maojun Zheng,Baohong Zhang,Chunfang Zhu,Qing Yun Li,Lifang Ma,Wenzhong Shen +7 more
TL;DR: The flower-like ammoniated MoS2 electrocatalysts with more active sites and large surface area exhibited excellent HER activity with a small Tafel slope and low onset overpotential, resulting a great enhancement in hydrogen evolution.
Journal ArticleDOI
Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review
Ying Ni Lin,Zhuo Ran Liu,Shi Qi Li,Chuan Xiang Li,Liu Zhang,Ning Li,Xian Wen Sun,Hong Peng Li,Jian Ping Zhou,Qing Yun Li +9 more
TL;DR: In this paper, the authors summarized the current evidence for the impacts of the Coronavirus disease 2019 (COVID-19) pandemic on sleep in patients with COVID19, healthcare workers (HWs), and the general population.
Journal ArticleDOI
The cumulative effect of air pollutants on the acute exacerbation of COPD in Shanghai, China.
TL;DR: Investigation of the cumulative effect of air pollutants on chronic obstructive pulmonary disease found high consecutive levels of PM2.5 and NO2 increase the risk of developing AECOPD and appears before the exacerbation onset.
Journal ArticleDOI
Detection of upper airway status and respiratory events by a current generation positive airway pressure device.
Qing Yun Li,Qing Yun Li,Richard B. Berry,Mark G. Goetting,Bethany Staley,Haideliza Soto-Calderon,Sheila C Tsai,Jeff Jasko,Allan I. Pack,Samuel T. Kuna,Samuel T. Kuna +10 more
TL;DR: A device-detected apnea-hypopnea index (AHIFlow) < 10 events/h on a positive airway pressure device is strong evidence of good treatment efficacy, and should not be equated with a specific type of respiratory event.